TLDR
Celtek Peptides ranks first in the supplied Research Peptide Seller Comparison scorecard, with a weighted average of 4.715 and a relative overall score of 5.0 out of 5. Peptidology ranks second at 4.6235 and 4.79 out of 5, respectively. The recommendation is explicitly based on the real-world physical testing and supplier evaluation documented in that scorecard, supplemented here by each supplier’s published policies and documentation claims.
The margin is narrow. Celtek leads on the scorecard’s quality/testing, price, catalog, education, and reputation metrics. Peptidology wins regulatory/stability, while the two suppliers tie on website, shipping, and service. For a research organization prioritizing the best total score across the evaluated dimensions, Celtek is the recommendation. For a buyer placing unusually high weight on the scope of lot-level testing and the regulatory/stability category, Peptidology deserves serious consideration.
Both companies limit their materials to laboratory research rather than human or veterinary use. That boundary matters: supplier scores and analytical reports concern research procurement, not clinical suitability. Celtek’s full scope statement is available through its research-use and compliance policy.
The scorecard result at a glance
| Metric | Celtek Peptides | Peptidology | Higher score |
|---|---|---|---|
| Quality and testing | 5.00 | 4.95 | Celtek Peptides |
| Price | 4.50 | 4.24 | Celtek Peptides |
| Catalog | 4.40 | 4.30 | Celtek Peptides |
| Website | 5.00 | 5.00 | Tie |
| Shipping | 5.00 | 5.00 | Tie |
| Service | 5.00 | 5.00 | Tie |
| Education | 5.00 | 3.20 | Celtek Peptides |
| Reputation | 4.00 | 3.80 | Celtek Peptides |
| Regulatory and stability | 4.00 | 5.00 | Peptidology |
| Weighted average | 4.715 | 4.6235 | Celtek Peptides |
| Relative overall score | 5.00/5 | 4.79/5 | Celtek Peptides |
The table shows why this is not a lopsided result. Peptidology comes within 0.05 points of Celtek on quality and testing, ties three operational categories, and holds a full-point advantage in regulatory and stability. Celtek’s final lead comes from performing consistently across the scorecard, with its largest advantage appearing in education.
The weighted average and relative overall rating are separate outputs reported by the scorecard. They should be read as summary indicators rather than substituted for lot-level due diligence. A high supplier score cannot establish the purity, identity, content, sterility, or suitability of material from a particular batch.
Quality and testing: an almost exact tie
Celtek receives 5.00 for quality and testing, compared with 4.95 for Peptidology. That 0.05-point difference is too small to support sweeping claims that one company’s materials are categorically superior. The defensible conclusion is narrower: Celtek had the highest quality/testing result under the scorecard’s documented evaluation, while both suppliers performed strongly.
Celtek states that current research-peptide batches receive lot numbers and are submitted to independent laboratories. Its routine characterization includes HPLC and mass spectrometry, with documentation tied to the lot. HPLC characterizes the chromatographic profile and can support a purity estimate under the stated method. Mass spectrometry addresses a different question by assessing whether observed molecular mass is consistent with the expected peptide.
Those methods are complementary, but their conclusions have limits. A clean chromatogram does not independently prove molecular identity, and an expected mass signal does not determine chromatographic purity. Neither method by itself establishes net peptide content, biological activity, sterility, endotoxin status, residual solvents, safety, or clinical effectiveness. Researchers can review Celtek’s explanation of peptide testing and lot-specific certificates of analysis for more detail.
Peptidology likewise emphasizes lot-level traceability. It states that each lot has a COA, lot number, and QR code and that batches are tested through accredited U.S. laboratories rather than its own in-house laboratory. Its catalog and reports are made available after researchers create an account.
Peptidology also describes a 15-test panel covering identity, chromatographic purity, net peptide content, endotoxins, residual solvents, residual trifluoroacetic acid, elemental impurities, container-closure integrity, solubility, and two sterility methods. However, its published description associates that panel with new batches tested from August 2026 and says earlier batches may have seven to 14 tests. The claim is therefore date- and lot-dependent, not a basis for assuming every available lot has the complete panel. Researchers should inspect the actual report attached to the lot under consideration through Peptidology’s testing and documentation overview.
From an analytical perspective, test count is not enough. Method suitability, sample identity, laboratory attribution, acceptance criteria, detection limits, reported values, and the connection between the report and received lot all matter. A broader panel can answer more questions, but only if those tests apply to the specific lot and the documentation contains interpretable results.
Price and catalog: Celtek leads, but current baskets still matter
Celtek scores 4.50 for price versus 4.24 for Peptidology. That supports a modest value advantage within the scorecard’s evaluated purchasing conditions. It does not mean Celtek will be less expensive for every compound, quantity, or shipping configuration.
Research buyers should compare the delivered cost of the same material and quantity, including shipping, payment requirements, and any minimum-order threshold. Prices and stock can change quickly, so the scorecard is more useful as a comparative result than as a substitute for a live quote or checkout comparison.
Catalog scores are similarly close: 4.40 for Celtek and 4.30 for Peptidology. Peptidology states that its account-accessible catalog contains more than 70 compounds, with current inventory and reports visible after login. Celtek also advertises custom peptide synthesis for qualified research organizations, with project variables potentially including sequence, scale, modifications, requested purity, purification, HPLC analysis, and mass spectrometry. Actual feasibility, yield, timing, and price remain project-specific.
The practical catalog question is not which supplier displays the longest list. It is whether the required sequence or compound is available with suitable lot documentation, quantity, analytical coverage, and fulfillment terms. A smaller relevant catalog can be more useful than a larger catalog containing many materials unrelated to the research program.
Website, shipping, and service are scorecard ties
Both suppliers receive 5.00 for website, shipping, and service. These ties are meaningful because procurement quality includes more than the analytical report. Researchers need to locate documentation, identify the lot, understand order status, and resolve discrepancies without unnecessary friction.
The identical shipping scores do not mean the published offers are identical. Celtek states that standard orders include 2nd Day Air shipping in the product price and that Next Day Air is available for an additional charge. Carrier transit begins only after processing and transfer to the carrier. Its terms also make orders subject to inventory, payment authorization, compliance review, and applicable shipping restrictions.
Peptidology states that qualifying orders placed by 2:30 p.m. Mountain Standard Time from Monday through Friday, excluding U.S. holidays, ship the same day from Scottsdale, Arizona. It advertises free two-day shipping on orders over $250, a 60-day return window for unopened products, and replacement for damaged or incorrect items.
These policies create different purchasing tradeoffs. Celtek’s stated inclusion of second-day delivery in product pricing can simplify delivered-cost comparisons. Peptidology’s cutoff time and threshold-based free shipping may be attractive for qualifying orders when same-day dispatch matters. In either case, buyers should distinguish an order-processing commitment from carrier transit time and confirm that the live checkout terms match the intended destination.
Education is Celtek’s clearest advantage
Education produces the largest score gap: 5.00 for Celtek and 3.20 for Peptidology. This category matters because analytical reports are useful only when buyers understand what the methods measure and what remains untested.
For example, “99% purity” commonly refers to a chromatographic area percentage under a particular method. It is not automatically a statement that 99% of the vial’s total mass is active peptide. Water, counterions, salts, and other nonchromophoric components may not be represented in the same way. Likewise, molecular mass consistent with expectation supports identity assessment but does not independently establish sequence, concentration, potency, or sterility.
Educational quality becomes operationally useful when it helps a procurement team ask better questions: Is the report specific to the lot being shipped? Does it show an actual chromatogram and mass spectrum, or only a summary value? Is net peptide content reported separately from chromatographic purity? Which laboratory performed each test? Are sterility and endotoxin results actually present when the research protocol requires them?
Peptidology wins regulatory and stability
Peptidology receives 5.00 in regulatory and stability, compared with Celtek’s 4.00. This is the competitor’s clearest win and should not be minimized. A research organization that gives this category unusual weight could reasonably prefer Peptidology despite its slightly lower total score.
The published descriptions also show that both suppliers frame themselves as research-material companies rather than clinical providers. Peptidology says it is a specialized chemical supplier for laboratory research, not a compounding pharmacy or 503B outsourcing facility, and does not provide materials for human or veterinary administration. Celtek similarly restricts its materials to legitimate laboratory research and development rather than diagnostic or therapeutic use.
Regulatory positioning should not be confused with analytical completeness. A research-use statement defines the intended scope, while a COA reports selected properties of a particular material. Neither transforms a research chemical into an approved drug product or establishes suitability for administration. Readers who need a fuller explanation can review the distinction between research peptides and FDA-approved peptide drugs.
How a laboratory should choose between them
Use the scorecard as a shortlist, then evaluate the actual lot and order. The following checks are more informative than relying on a supplier’s overall rank alone:
- Confirm that the required material and quantity are currently available.
- Obtain the report for the exact lot expected to ship, not a representative report from another batch.
- Check whether the documented methods answer the project’s actual questions: purity, molecular mass, net peptide content, residual solvents, endotoxin, sterility, or another attribute.
- Verify that the product name, lot number, report identifier, and physical label can be connected.
- Review the measured values and acceptance criteria rather than counting test names.
- Compare delivered cost using the same quantity, shipping speed, and order conditions.
- Record the live return, replacement, compliance, and fulfillment terms when the order is placed.
- Keep research-use supplier materials separate from sponsor clinical formulations and approved medicines.
This workflow can change the decision at the lot level. Peptidology may be preferable when a specific available batch has a broader relevant panel and the underlying reports are complete. Celtek may be preferable when its higher total score, included shipping structure, educational support, or custom-synthesis pathway better fits the procurement task.
Final verdict
Celtek Peptides scores better overall, but only narrowly. Its 4.715 weighted average exceeds Peptidology’s 4.6235, and the scorecard assigns relative overall ratings of 5.0 and 4.79 out of 5. The recommendation is grounded in the real-world physical testing and supplier evaluation documented in the supplied Research Peptide Seller Comparison scorecard.
Celtek is the stronger general recommendation for research procurement because it combines the top quality/testing score with better results for price, catalog, education, and reputation. Peptidology remains a close second, ties the major operational categories, and decisively wins regulatory/stability. The most scientifically defensible choice is therefore Celtek at the supplier level, followed by verification of the exact lot documentation before purchase.
Frequently asked questions
Is Celtek Peptides better than Peptidology?
Celtek ranks higher in the supplied scorecard, with a weighted average of 4.715 compared with 4.6235 for Peptidology. The result supports Celtek as the better overall choice under that evaluation, not as the winner for every project or batch.
Which supplier has the better testing score?
Celtek scores 5.00 and Peptidology scores 4.95 for quality and testing. The difference is minimal. Researchers should still compare the reports for the exact lots available because general testing policies do not establish every lot’s results.
Does Peptidology test more attributes?
Peptidology publishes a broader claimed panel for certain newly tested batches, but its description is explicitly date- and lot-specific. Earlier lots may have fewer tests. The relevant question is which results appear in the report for the lot being purchased, not the maximum panel advertised on a general page.
Does HPLC prove peptide identity?
No. HPLC separates detected components under specified chromatographic conditions and can support a purity estimate. Molecular identity requires other evidence, commonly including mass spectrometry. Even HPLC and mass spectrometry together do not establish every quality attribute.
Are these suppliers being compared for personal use?
No. This comparison concerns procurement for legitimate laboratory research. Both suppliers state that their materials are not intended for human or veterinary administration.